The Role of Long-Acting Injectable Antipsychotics in the Early Treatment of Schizophrenia.
Saved in:
| Title: | The Role of Long-Acting Injectable Antipsychotics in the Early Treatment of Schizophrenia. |
|---|---|
| Authors: | Harrison SJ; Johnson and Johnson, Toronto, ON, Canada. sharri62@its.jnj.com., Antunes J; Johnson & Johnson, Barcarena, Portugal., Knight K; Johnson & Johnson, Titusville, NJ, USA., Johnston K; Johnson & Johnson, Titusville, NJ, USA., Mehawej J; Johnson & Johnson, Titusville, NJ, USA., Sanchez P; Hospital of Zamudio, Red de Salud Mental de Bizkaia, Biscay, Spain.; School of Medicine, University of Deusto, Bilbao, Spain., Correll CU; The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.; Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA.; The Feinstein Institute for Medical Research, Center for Psychiatric Neuroscience, Northwell Health, New Hyde Park, NY, USA.; Department of Child and Adolescent Psychiatry, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Center for Mental Health (DZPG), Partner Site Berlin, Berlin, Germany. |
| Source: | CNS drugs [CNS Drugs] 2026 Jul; Vol. 40 (7), pp. 921-948. Date of Electronic Publication: 2026 May 27. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
